Inhibin beta A drives colorectal cancer progression through macrophage M2 polarization and mitochondria-dependent ferroptosis suppression
Wentao Li, Lin Liang, Siyi Liu, Jingqiong Tang, Shuangyan Ou, Zhijun Yuan, Yanhong Zhou, Xia Yuan · 2025
Read Inhibin beta A drives colorectal cancer progression through macrophage M2 polarization and mitochondria-dependent ferroptosis suppression by Wentao Li, Lin Liang, Siyi Liu, Jingqiong Tang, Shuangyan Ou, Zhijun Yuan, Yanhong Zhou, Xia Yuan (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12741050.txt.
Description
Eight authors led by Wentao Li find a growth factor that drives bowel cancer on two fronts at once. Bowel cancer is a common killer whose growth rules are still partly dark. The factor, called INHBA, sat high in tumour tissue and tracked with poor outcomes for patients. In dish and mouse tests, high levels sped cancer cell growth, spread, and tissue entry. Cutting the factor slowed all three.
One front is immune: the factor flips guard cells near the tumour to a state that shelters it. The flip runs through a carrier protein the factor also shields from cell trash runs. The other front is cell death: the factor blocks a rust-like death path inside cancer cell power units. Both fronts make INHBA a drug target of note for bowel cancer.
Catalog record
| CREATOR | Wentao Li, Lin Liang, Siyi Liu, Jingqiong Tang, Shuangyan Ou, Zhijun Yuan, Yanhong Zhou, Xia Yuan |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 92 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |